Insulin lispro (Humalog®, rDNA origin), a rapid-acting mealtime human insulin analog.

被引：0

作者：

Anderson, JH ^{[1
]}

Chance, RE ^{[1
]}

DiMarchi, RD ^{[1
]}

Frank, BH ^{[1
]}

机构：

[1] Lilly Res Labs, Indianapolis, IN 46285 USA

来源：

ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 215卷

关键词：

D O I：

暂无

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

108-MEDI

引用

页码：U892 / U892

页数：1

共 50 条

[31] Insulin aspart in a 30/70 premixed formulation - Pharmacodynamic properties of a rapid-acting insulin analog in stable mixture
Weyer, C
Heise, T
Heinemann, L
[J]. DIABETES CARE, 1997, 20 (10) : 1612 - 1614
[32] Insulin glulisine: a new rapid-acting insulin analogue for the treatment of diabetes
Garg, SK
Ellis, SL
Ulrich, H
[J]. EXPERT OPINION ON PHARMACOTHERAPY, 2005, 6 (04) : 643 - 651
[33] Pharmacodynamic properties of Viaject™:: A novel rapid-acting regular human insulin
Steiner, Solomon S.
Hompesch, Marcus
Pohl, Roderike
Simms, Patrick
Pfuetzner, Andreas
Forst, Thomas
Heinemann, Lutz
[J]. DIABETES, 2006, 55 : A27 - A27
[34] Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T1D
Linnebjerg, Helle
Zhang, Qianyi
Labell, Elizabeth S.
Reddy, Shobha
Coutant, David E.
Hoevelmann, Ulrike
Plum-Moerschel, Leona
Herbrand, Theresa
Leohr, Jennifer
[J]. DIABETES, 2019, 68
[35] Similar pharmacokinetics and pharmacodynamics of rapid-acting insulin lispro products SAR342434 and US- and EU-approved Humalog in subjects with type 1 diabetes
Kapitza, Christoph
Nowotny, Irene
Lehmann, Anne
Bergmann, Karin
Rotthaeuser, Baerbel
Nosek, Leszek
Becker, Reinhard H. A.
[J]. DIABETES OBESITY & METABOLISM, 2017, 19 (05): : 622 - 627
[36] Real-world efficacy and safety of insulin degludec with mealtime rapid-acting insulin in type 1 diabetes in Indian pediatric population
Kochar, Inderpal Singh
Sethi, Aashish
[J]. INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY, 2018,
[37] Ultra Rapid Lispro (URLi) Accelerates Insulin Lispro Absorption and Insulin Action vs. Humalog (Lispro) in Patients with T2D
Leohr, Jennifer
Dellva, Mary A.
Coutant, David E.
Labell, Elizabeth S.
Reddy, Shobha
Heise, Tim
Andersen, Grit
Zijlstra, Eric
Hermanski, Lidia
Nosek, Leszek
Linnebjerg, Helle
[J]. DIABETES, 2019, 68
[38] Dance-501 Inhaled Human Insulin Has a Dose-Linear Response and Similar Within-Subject Variability as Rapid-Acting Insulin Lispro
Zijlstra, Eric
Heise, Tim
Nosek, Leszek
Coester, Hans-Veit
Lueckemeyer, Kathrin
Porter, Lisa
Miller, Samantha
Vick, Andy
Fink, James B.
Patton, John
[J]. DIABETES, 2015, 64 : A248 - A248
[39] Patient reported outcomes in adults with type 2 diabetes on basal insulin randomized to addition of mealtime pramlintide or rapid-acting insulin analogs
Peyrot, Mark
Rubin, Richard R.
Polonsky, William H.
Best, Jennie H.
[J]. CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1047 - 1054
[40] A comparison of the usability of two types of disposable pen (FlexPen versus Humalog kit) containing rapid-acting insulin analogs
Asakura, T
Seino, H
[J]. DIABETES, 2003, 52 : A102 - A102

← 1 2 3 4 5 →